SEARCH BY
| Category | Company |
|---|---|
| Founded | 1952 |
| Sector | Life Science |
| Employees | 13,800 |
| Revenue | 9.3B USD (2024) |
Zoetis engages in the discovery, development, manufacture and commercialization of a diverse portfolio of animal health medicines and vaccines designed to meet the real-world needs of veterinarians and the livestock farmers and companion animal owners they support. Zoetis was founded in 1952 and is based in Parsippany, New Jersey.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 13 |
| Sector: Life Science M&A | 3 of 7 |
| Type: Add-on Acquisition M&A Deals | 3 of 12 |
| State: Louisiana M&A | 1 of 1 |
| Country: United States M&A | 2 of 8 |
| Year: 2008 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-03-18 |
Catapult Genetics Pty.
Albion, Australia Catapult is a global provider of sheep and cattle DNA testing technologies for meat and carcass quality and production efficiency under the GeneSTAR® Quality Grade, Feed Efficiency, the SureTRAK® system, and the SireTRACETM product brands. In addition to co-founders Gerard Davis and Jay Hetzel, shareholders include AgResearch, CSIRO, Kestrel Capital’s Nanyang Innovation Fund, and Meat & Wool New Zealand. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-11-10 |
PHARMAQ Holding AS
Overhalla, Norway PHARMAQ Holding AS is a pharmaceutical company focused on aquaculture. It develops, manufactures and markets vaccines and therapeutic products for the prevention and treatment of diseases in farmed fish. |
Buy | $765M |
